Why Amcor, Ioneer, Novonix, and ResMed shares are charging higher

These ASX shares are catching the eye on Wednesday.

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on form and charging higher. At the time of writing, the benchmark index is up 0.7% to 6,825.9 points.

Four ASX shares that are rising more than most today are listed below. Here's why they are climbing:

A man in a blue collared shirt sits at his desk doing a single fist pump as he watches the Appen share price rise on his laptop

Image source: Getty Images

Amcor PLC (ASX: AMC)

The Amcor share price is up 2% to $14.13. This follows the release of the packaging company's quarterly update. Although Amcor reported a 7% decline in sales to US$3,443 million and a 9% fall in EBIT to US$392 million, it seems the market was expecting a greater decline. Management has reaffirmed its guidance for FY 2024.

Ioneer Ltd (ASX: INR)

The Ioneer share price is up 11% to 15.5 cents. Investors have been buying this lithium share today after it announced a memorandum of understanding with battery grade high purity lithium hydroxide conversion company EcoPro Innovation. EcoPro will conduct research and development on the lithium clay resource found at Ioneer's Rhyolite Ridge project. The goal will be to develop a process to commercialise the lithium clay to produce refined lithium materials for the U.S. electric vehicle battery supply chain.

Novonix Ltd (ASX: NVX)

The Novonix share price is up 13% to 76.5 cents. This has been driven by news that the battery materials technology company has secured US$100 million of funding from the US government. The money will support the installation and commissioning of equipment to produce the targeted 20,000 tonnes per annum (tpa) of capacity from its Riverside facility.

ResMed Inc (ASX: RMD)

The ResMed share price is up 4% to $22.69. This follows a strong session for the sleep treatment company's NYSE-listed shares. It seems that many investors believe that its shares have been oversold in recent months and are now piling back in.

Motley Fool contributor James Mickleboro has positions in ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed. The Motley Fool Australia has positions in and has recommended Amcor Plc and ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a shaky, but positive, session for the ASX this Tuesday.

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy start to the week's trading this Monday.

Read more »

Five young people sit in a row having fun and interacting with their mobile phones.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A woman's hand draws a stylised 'Top Ten' on a projected surface.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another disappointing session on the ASX this Thursday.

Read more »

3 children standing on podiums wearing Olympic medals.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a disappointing mid-week session today.

Read more »

Girl with painted hands.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy Tuesday session on the markets today.

Read more »

A woman is very excited about something she's just seen on her computer, clenching her fists and smiling broadly.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week for investors this Friday.

Read more »

A woman looks shocked as she drinks a coffee while reading the paper.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a brutal day on the markets this Thursday.

Read more »